Melinta Therapeutics to Present at the JMP Securities Life Sciences Conference

World News: . []

NEW HAVEN, Conn., June 13, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial infections, today announced that Dan Wechsler, President and CEO of Melinta, will present at the JMP Securities Life Sciences Conference in New York, NY. The presentation will take place on Weds., June 20 at 4:00 p.m. Eastern Time.

A live and archived webcast of the presentation will be accessible from Melinta’s Investor Relations website at . The webcast can also be accessed from the following URL: .

More news and information about Melinta Therapeutics

Published By:

Globe Newswire: 21:05 GMT Wednesday 13th June 2018

Published: .

Search for other references to "melinta" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us
 

Advertising on SPi News: Information For Advertisers